Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Liver Cirrhosis

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 140 articles: HTML format

Single Articles

January 2026
1. ROSE S, Ashraf MU, Shastri A, Priya K, et al
   Rifaximin Improves Frailty in Patients with Decompensated Cirrhosis: A Randomized Trial.
   Dig Dis Sci. 2026 Jan 24. doi: 10.1007/s10620-025-09660.
   PubMed     Abstract available
   
   
   December 2025
2. PATEL AA, Walling AM, Sudore RL, Tseng CH, et al
   Advance Directive Completion Among Community-Dwelling Adults with Decompensated Cirrhosis.
   Dig Dis Sci. 2025 Dec 27. doi: 10.1007/s10620-025-09616.
   PubMed     Abstract available
   
   
   
3. DODGE JL, Kim B
   Branched-Chain Amino Acid Supplementation in Patients with Cirrhosis: Boon, Bust, or Bull?
   Dig Dis Sci. 2025 Dec 16. doi: 10.1007/s10620-025-09614.
   PubMed    
   
   
   
4. ZHANG J, Ren Y
   Lean MASLD Cirrhosis and Mortality: Considerations for Liver Transplant Candidate Evaluation.
   Dig Dis Sci. 2025 Dec 11. doi: 10.1007/s10620-025-09601.
   PubMed    
   
   
   November 2025
5. MA AT, Sola E
   Differentiating Hepatorenal Syndrome from Acute Tubular Necrosis in Patients with Decompensated Cirrhosis: Can Metabolomics or Proteomics Help?
   Dig Dis Sci. 2025 Nov 12. doi: 10.1007/s10620-025-09513.
   PubMed    
   
   
   
6. MA S, Alsabawi Y, Kanwal F, Duong H, et al
   The Association Between Physical Activity, Sedentary Time, and Sleep with Risk of Hepatocellular Carcinoma in Patients with Cirrhosis.
   Dig Dis Sci. 2025 Nov 7. doi: 10.1007/s10620-025-09527.
   PubMed     Abstract available
   
   
   October 2025
7. BISWAS S, Mehta S, Swaroop S, Aggarwal A, et al
   Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled Trial.
   Dig Dis Sci. 2025 Oct 27. doi: 10.1007/s10620-025-09485.
   PubMed     Abstract available
   
   
   
8. ISMAIL A, Abusuliman M, Kloub M, Abbarh S, et al
   Comparative Risk of Recurrent Esophageal Variceal Hemorrhage and Other Decompensation Events with Carvedilol Versus Propranolol in Patients with Cirrhosis: A Retrospective Study.
   Dig Dis Sci. 2025 Oct 18. doi: 10.1007/s10620-025-09453.
   PubMed     Abstract available
   
   
   
9. HAIMI M, Baker FA, Vinker S, Safadi R, et al
   Association Between High FIB-4 Score and the Risk of Malignancy Development and Mortality: A Retrospective Longitudinal Case-Control Study.
   Dig Dis Sci. 2025;70:3525-3537.
   PubMed     Abstract available
   
   
   September 2025
10. CULLARO G, Allegretti AS, Patidar KR, Verna EC, et al
    Embracing Imperfect Tools to Decode AKI in Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Sep 7. doi: 10.1007/s10620-025-09379.
    PubMed    
    
    
    
11. NG N, Purkayastha S, Ying X, Jesudian A, et al
    Socioeconomic Factors Impact the Perception of Healthcare Experiences in Patients with Cirrhosis.
    Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09374.
    PubMed     Abstract available
    
    
    
12. JINDAL A, Singh H, Sharma MK, Vashistha C, et al
    Correlation of Spleen Stiffness with Esophageo-gastric Variceal Bleeding in Patients with Non-cirrhotic Portal Hypertension.
    Dig Dis Sci. 2025 Sep 2. doi: 10.1007/s10620-025-09356.
    PubMed     Abstract available
    
    
    August 2025
13. RAO AK, Rockey DC
    Impact of Levothyroxine on Progression to and Complications of Cirrhosis in MASH.
    Dig Dis Sci. 2025 Aug 30. doi: 10.1007/s10620-025-09375.
    PubMed     Abstract available
    
    
    
14. FAIZ M, Usman M, Irshad NUN
    Clinical Insights on "Applying Metabolomics and Aptamer-Based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney Injury".
    Dig Dis Sci. 2025 Aug 19. doi: 10.1007/s10620-025-09329.
    PubMed    
    
    
    
15. ALDIABAT M, Aljabiri Y, Aleyadeh W, Madi MY, et al
    Branched-Chain Amino Acid Supplementation and Clinical Outcomes in Liver Cirrhosis: A Propensity Score-Matched Multicenter Retrospective Cohort Study.
    Dig Dis Sci. 2025 Aug 5. doi: 10.1007/s10620-025-09258.
    PubMed     Abstract available
    
    
    
16. CULLARO G, Allegretti AS, Patidar KR, Verna EC, et al
    Applying Metabolomics and Aptamer-Based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney Injury.
    Dig Dis Sci. 2025 Aug 1. doi: 10.1007/s10620-025-09223.
    PubMed     Abstract available
    
    
    July 2025
17. MASOOD M, Inamdar S, Thandassery RB
    Opposition Research: Endoscopic Management of Acute Cholecystitis in Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Jul 29. doi: 10.1007/s10620-025-09272.
    PubMed    
    
    
    
18. KARIM A, Memon S, Irshad NUN, Jaslok F, et al
    Critical Appraisal of Cystic Duct Stenting Versus Other Treatment Modalities for the Management of Acute Cholecystitis in Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Jul 28. doi: 10.1007/s10620-025-09284.
    PubMed    
    
    
    
19. WENTWORTH BJ, Geng CX, Novicoff WM, Siragy HM, et al
    Adrenal Dysfunction in Outpatients with Decompensated Cirrhosis: Impairment in the Hypothalamic-Pituitary-Adrenal Axis.
    Dig Dis Sci. 2025 Jul 26. doi: 10.1007/s10620-025-09237.
    PubMed     Abstract available
    
    
    
20. FAISAL MS, Harris KB, Faisal MS, Ashraf T, et al
    Cystic Duct Stenting Versus Other Treatment Modalities for the Management of Acute Cholecystitis in Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Jul 10. doi: 10.1007/s10620-025-09163.
    PubMed     Abstract available
    
    
    
21. THANDASSERY RB, John N, Mashal FA, Timmermann CJ, et al
    Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2025 Jul 3. doi: 10.1007/s10620-025-09193.
    PubMed     Abstract available
    
    
    June 2025
22. PAREDES-MARIN A, Napoli J, Sivakumar V, Near C, et al
    Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/Steatohepatitis.
    Dig Dis Sci. 2025 Jun 19. doi: 10.1007/s10620-025-09138.
    PubMed     Abstract available
    
    
    
23. LI R, Lee S, Caldwell PC, Tsavaris KL, et al
    In-Hospital Outcomes of Patients with Hepatorenal Syndrome Who Underwent Transjugular Intrahepatic Portosystemic Shunt Procedure.
    Dig Dis Sci. 2025 Jun 11. doi: 10.1007/s10620-025-09130.
    PubMed     Abstract available
    
    
    
24. BELCHER JM
    Predicting the Use of Dialysis for Acute Kidney Injury in Patients with Cirrhosis-Does Diagnosis Matter?
    Dig Dis Sci. 2025 Jun 5. doi: 10.1007/s10620-025-09143.
    PubMed    
    
    
    
25. LIU X, Xia Y, Zhu J, Liu X, et al
    Long-Term Outcomes of Carvedilol Plus Endoscopic Variceal Ligation in Secondary Prophylaxis of Variceal Bleeding.
    Dig Dis Sci. 2025;70:2138-2146.
    PubMed     Abstract available
    
    
    
26. MA C, Goldberg DS
    Impact of the Underutilization of Vibration-Controlled Transient Elastography in MASLD Patients Without Insurance Coverage.
    Dig Dis Sci. 2025;70:2007-2015.
    PubMed     Abstract available
    
    
    
27. ATTANASI ML, Gregoski MJ, Rockey DC
    Racial Differences in Liver Fibrosis Burden.
    Dig Dis Sci. 2025;70:2178-2185.
    PubMed     Abstract available
    
    
    May 2025
28. JALIL S, Mumtaz K
    Heart of the Matter: Uncovering the Link Between Heart Failure and Cirrhosis Mortality.
    Dig Dis Sci. 2025 May 19. doi: 10.1007/s10620-025-09092.
    PubMed    
    
    
    April 2025
29. ABUSULIMAN M, Dawod S, Nimri F, Jamali T, et al
    Predictive Factors of Post-ERCP Hepatic Decompensation in Patients with Cirrhosis: A Retrospective Case-Control Study.
    Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09071.
    PubMed     Abstract available
    
    
    
30. ABREU ES, Reginato PH, Pitanga JFJ, Borges PN, et al
    Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Apr 19. doi: 10.1007/s10620-025-09044.
    PubMed     Abstract available
    
    
    
31. AZIZ S, Hamid A, Shaikh A, Mansoor R, et al
    Unveiling Disparities in Heart Failure and Cirrhosis Related Mortality: CDC WONDER 1999 to 2020.
    Dig Dis Sci. 2025 Apr 10. doi: 10.1007/s10620-025-08970.
    PubMed     Abstract available
    
    
    
32. TAO T, Lv L, Chen J, He Y, et al
    Identification of Crosstalk Genes Between Primary Sjogren's Syndrome and Primary Biliary Cirrhosis by Transcriptome Analysis.
    Dig Dis Sci. 2025 Apr 8. doi: 10.1007/s10620-025-08917.
    PubMed     Abstract available
    
    
    
33. SOGBE M, Hummer B, Stine JG, Lizaola-Mayo B, et al
    Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2025;70:1530-1539.
    PubMed     Abstract available
    
    
    March 2025
34. FAN T, Zhu X, Ma X, Yin B, et al
    Severe Hyperhomocysteinemia, an Unusual Case of Liver Cirrhosis.
    Dig Dis Sci. 2025 Mar 28. doi: 10.1007/s10620-025-09006.
    PubMed    
    
    
    
35. TRUONG E, Alnimer L, Gornbein JA, Yang JD, et al
    Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD.
    Dig Dis Sci. 2025 Mar 24. doi: 10.1007/s10620-025-08850.
    PubMed     Abstract available
    
    
    
36. WAIDYARATNE G, Jalil S, Liu A, Liyanarachchi S, et al
    Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt.
    Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08940.
    PubMed     Abstract available
    
    
    February 2025
37. LOEFFLER J, Hassan M, Qaqish F, Dimachkie R, et al
    Predictors of Renal Replacement Therapy Requirement in Cirrhotic Patients with Acute Kidney Injury.
    Dig Dis Sci. 2025 Feb 15. doi: 10.1007/s10620-025-08881.
    PubMed     Abstract available
    
    
    
38. HOLMAN A, Solano Q, Firn J, Tapper E, et al
    Clinical Ethics Consultations in Cirrhosis Care.
    Dig Dis Sci. 2025 Feb 8. doi: 10.1007/s10620-025-08866.
    PubMed     Abstract available
    
    
    
39. SINGH V, De A, Aggrawal R, Singh A, et al
    Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study.
    Dig Dis Sci. 2025;70:835-842.
    PubMed     Abstract available
    
    
    January 2025
40. BISWAS S, Lo GH, Mehta S, Elhence A, et al
    Abbreviated Duration of Vasoactive Agents Has Similar Outcomes as Standard Duration of Therapy in Patients with Liver Cirrhosis and Variceal Bleeding: An Individual Patient Data Meta-Analysis.
    Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08851.
    PubMed     Abstract available
    
    
    
41. NJEI B, Mezzacappa C, John BV, Serper M, et al
    Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study.
    Dig Dis Sci. 2025 Jan 8. doi: 10.1007/s10620-024-08764.
    PubMed     Abstract available
    
    
    
42. CELAJ S, Estevez J, Novelli P, Orons P, et al
    Challenges and Opportunities in the Adoption of p-TIPS for Acute Variceal Bleeding: Insights from a US Tertiary Center.
    Dig Dis Sci. 2025;70:399-405.
    PubMed     Abstract available
    
    
    December 2024
43. YAKOVCHENKO V, Chang MF, Hernaez R, Awad JA, et al
    Access to Evaluation for Liver Transplantation in the Veterans Health Administration.
    Dig Dis Sci. 2024 Dec 11. doi: 10.1007/s10620-024-08717.
    PubMed     Abstract available
    
    
    
44. CUMPIAN NA, Choi G, Saab S
    Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis.
    Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08742.
    PubMed     Abstract available
    
    
    November 2024
45. LOYOLA-VELEZ AJ, John BV
    SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.
    Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08703.
    PubMed    
    
    
    
46. VERMA M, Chan M, Toroghi S, Gallagher M, et al
    Multimedia-Based Education Led to Improvement in Disease Knowledge Among Patients with Cirrhosis.
    Dig Dis Sci. 2024 Nov 7. doi: 10.1007/s10620-024-08704.
    PubMed     Abstract available
    
    
    
47. GOYAL T, Song MW, Suresh D, Jasty VSJ, et al
    Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:4250-4258.
    PubMed     Abstract available
    
    
    
48. JASTY VSJ, Urias E, Le Ashley Tiong K, Aboona MB, et al
    Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort Study.
    Dig Dis Sci. 2024;69:4240-4249.
    PubMed     Abstract available
    
    
    October 2024
49. LIU ZW, Song T, Wang ZH, Sun LL, et al
    Predicting Portal Pressure Gradient in Patients with Decompensated Cirrhosis: A Non-invasive Deep Learning Model.
    Dig Dis Sci. 2024 Oct 28. doi: 10.1007/s10620-024-08701.
    PubMed     Abstract available
    
    
    
50. JINDAL A, Kumar G, Sharma MK, Vashishtha C, et al
    Derivation of Splenic Stiffness in Subjects with Normal Liver Stiffness and No Vascular Liver Disease Using Transient Elastography with a Spleen-Dedicated Module: A Large Cross Sectional Study.
    Dig Dis Sci. 2024;69:3942-3951.
    PubMed     Abstract available
    
    
    September 2024
51. PATEL KM, Zhang J, Marsden J, Bays C, et al
    Missed and Delayed Diagnoses of Chronic Liver Disease in Primary Care Patients with Cirrhosis.
    Dig Dis Sci. 2024 Sep 20. doi: 10.1007/s10620-024-08601.
    PubMed     Abstract available
    
    
    
52. SOLANO QP, Chen X, Parikh ND, Tapper EB, et al
    Racial and Ethnic Disparities in Outcomes After the Development of Ascites: A National Cohort Study.
    Dig Dis Sci. 2024;69:3214-3219.
    PubMed     Abstract available
    
    
    August 2024
53. DIAZ PM, Saly DL, Horick N, Petrosyan R, et al
    Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy.
    Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623.
    PubMed     Abstract available
    
    
    
54. HU Y, Zhou M, Liu D, Gong J, et al
    Risk Factors for Rebleeding After Endoscopic Injection of Cyanoacrylate Glue for Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2024;69:2890-2903.
    PubMed     Abstract available
    
    
    July 2024
55. IFRAH A, Fromer R, Gayner AH, Yeung HM, et al
    Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Jul 31. doi: 10.1007/s10620-024-08574.
    PubMed     Abstract available
    
    
    
56. EDELSON JC, Rockey DC
    Safety of Endoscopy in Cirrhosis.
    Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
    PubMed     Abstract available
    
    
    
57. CHANG CW, Hsu WF, Tseng KC, Chen CY, et al
    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
    Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08512.
    PubMed     Abstract available
    
    
    
58. STERN C, Ngo A, Villela-Nogueira C, Thabut D, et al
    A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
    Dig Dis Sci. 2024;69:2648-2654.
    PubMed     Abstract available
    
    
    June 2024
59. BROWN C, Hernandez R, Ford T, Aksan N, et al
    Inadequate Dietary Education and Poor Adherence to a High Protein, Low Sodium Diet in Cirrhosis: Mixed Methods Approach.
    Dig Dis Sci. 2024 Jun 28. doi: 10.1007/s10620-024-08526.
    PubMed     Abstract available
    
    
    
60. FULLER SR, Schreiner AD
    Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges.
    Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08498.
    PubMed    
    
    
    May 2024
61. KOCH DG, Rockey DC, Litwin SS, Tedford RJ, et al
    H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
    Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08438.
    PubMed     Abstract available
    
    
    
62. PEMMASANI G, Tremaine W, Karagozian R, John S, et al
    Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
    PubMed     Abstract available
    
    
    
63. THRIFT AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, et al
    An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
    PubMed     Abstract available
    
    
    April 2024
64. HSIEH HC, Chang WP, Huang PJ, Wang CH, et al
    Effectiveness of Exercise Interventions on Body Composition, Exercise Capacity, Fatigue, and Quality of Life in Patients with Liver Cirrhosis: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08447.
    PubMed     Abstract available
    
    
    
65. LEE DU, Bhowmick K, Kolachana S, Schuster K, et al
    Inpatient Cost Burdens of Treating Chronic Hepatitis B in US Hospitals: A Weighted Analysis of a National Database.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08448.
    PubMed     Abstract available
    
    
    
66. HORBAL SR, Belancourt PX, Zhang P, Holcombe SA, et al
    Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08450.
    PubMed     Abstract available
    
    
    
67. MANNING ME, Fricker Z
    Cardiopulmonary Resuscitation Outcomes and Trainee Perception of Code Status Discussions in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08443.
    PubMed     Abstract available
    
    
    
68. WEBER S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, et al
    Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08446.
    PubMed     Abstract available
    
    
    
69. CHANG ML, Le PH, Chen WT, Chen TD, et al
    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
    PubMed     Abstract available
    
    
    
70. MOON AM, Swier RM, Lane LM, Barritt AS 4th, et al
    Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08442.
    PubMed     Abstract available
    
    
    
71. MCCURDY H, Nobbe A, Scott D, Patton H, et al
    Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.
    Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
    PubMed     Abstract available
    
    
    
72. PEARLMAN BL
    Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
    PubMed     Abstract available
    
    
    
73. KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
    Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
    Dig Dis Sci. 2024;69:1430-1443.
    PubMed     Abstract available
    
    
    
74. WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
    Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:1444-1453.
    PubMed     Abstract available
    
    
    
75. BEHARI J
    Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver Disease-Value Added or Work in Progress?
    Dig Dis Sci. 2024;69:1093-1095.
    PubMed    
    
    
    March 2024
76. ARSHAD T, Vainer D, Khan H, Baral A, et al
    Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
    PubMed     Abstract available
    
    
    
77. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
    Hospital-Level Care at Home for Patients with Cirrhosis.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
    PubMed     Abstract available
    
    
    
78. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
    Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
    PubMed     Abstract available
    
    
    
79. PATEL AA, Walling A, Bansal A
    A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
    PubMed    
    
    
    
80. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
    Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
    Dig Dis Sci. 2024;69:989-1003.
    PubMed     Abstract available
    
    
    February 2024
81. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    PubMed     Abstract available
    
    
    
82. CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
    PubMed     Abstract available
    
    
    
83. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
    Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
    PubMed     Abstract available
    
    
    
84. LI R, Sarin S
    Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
    Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
    PubMed     Abstract available
    
    
    
85. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
    Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
    Dig Dis Sci. 2024;69:643-644.
    PubMed    
    
    
    
86. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
    Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:370-383.
    PubMed     Abstract available
    
    
    January 2024
87. ASADA S, Namisaki T, Kaji K, Takaya H, et al
    VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
    Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
    PubMed     Abstract available
    
    
    
88. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
    A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
    PubMed     Abstract available
    
    
    
89. TSAI SY, O'Leary JG
    Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
    PubMed    
    
    
    
90. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
    Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
    PubMed     Abstract available
    
    
    
91. BLOOM PP, Che Z, Hyde A, Johnson E, et al
    Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
    PubMed     Abstract available
    
    
    December 2023
92. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.
    PubMed    
    
    
    
93. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    PubMed     Abstract available
    
    
    November 2023
94. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    PubMed     Abstract available
    
    
    
95. WONG ZY, Koh JH, Muthiah M, Koh B, et al
    Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
    PubMed     Abstract available
    
    
    
96. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    PubMed     Abstract available
    
    
    October 2023
97. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    PubMed     Abstract available
    
    
    
98. GONZALEZ HC, Trudeau S
    COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
    PubMed    
    
    
    
99. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
    Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
    PubMed     Abstract available
    
    
    
100. BANGARU S, Sundaresh R, Lee A, Prause N, et al
     Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
     PubMed     Abstract available
     
     
     
101. BUI HH, Nguyen ST, Phan ST, Nguyen KM, et al
     Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
     Dig Dis Sci. 2023 Oct 20. doi: 10.1007/s10620-023-08143.
     PubMed     Abstract available
     
     
     
102. LI R, Li M, Bidulescu A, Fly AD, et al
     Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
     Dig Dis Sci. 2023;68:4009-4021.
     PubMed     Abstract available
     
     
     September 2023
103. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
     MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
     Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
     PubMed     Abstract available
     
     
     
104. CHOI AY, Li X, Guo W, Chandan VS, et al
     Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3-4 Fibrosis.
     Dig Dis Sci. 2023;68:3774-3780.
     PubMed     Abstract available
     
     
     
105. MCNALLY BB, Rangan P, Wijarnpreecha K, Fallon MB, et al
     Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.
     Dig Dis Sci. 2023;68:3765-3773.
     PubMed     Abstract available
     
     
     July 2023
106. TAPPER EB, Saleh ZM, Lizza S, Chen X, et al
     CAREGIVER Randomized Trial of Two Mindfulness Methods to Improve the Burden and Distress of Caring for Persons with Cirrhosis.
     Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08042.
     PubMed     Abstract available
     
     
     
107. SUAREZ M, Martinez R, Torres AM, Torres B, et al
     A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis.
     Dig Dis Sci. 2023 Jul 21. doi: 10.1007/s10620-023-08031.
     PubMed     Abstract available
     
     
     
108. MOORE JA, Wheless WH, Zhang J, Marsden J, et al
     Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2023;68:2946-2953.
     PubMed     Abstract available
     
     
     
109. BROWN C, Aksan N, Chang P, Jagannathan P, et al
     Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR.
     Dig Dis Sci. 2023;68:2954-2962.
     PubMed     Abstract available
     
     
     June 2023
110. WENTWORTH BJ, Khot R, Caldwell SH
     The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds.
     Dig Dis Sci. 2023 Jun 26. doi: 10.1007/s10620-023-08003.
     PubMed     Abstract available
     
     
     
111. ATTANASI ML, Bou Daher H, Rockey DC
     Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.
     Dig Dis Sci. 2023 Jun 22. doi: 10.1007/s10620-023-07993.
     PubMed     Abstract available
     
     
     
112. MCHENRY S, Awad A, Kozlitina J, Stitziel NO, et al
     Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
     Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07980.
     PubMed     Abstract available
     
     
     
113. BOU DAHER H, Manka P, Syn WK
     Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?
     Dig Dis Sci. 2023;68:2217-2220.
     PubMed    
     
     
     
114. BERTOT LC, Jeffrey GP, de Boer B, Wang Z, et al
     Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan(R) to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2023;68:2757-2767.
     PubMed     Abstract available
     
     
     May 2023
115. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
     Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
     Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07969.
     PubMed     Abstract available
     
     
     
116. KAPLAN DE
     Statins in Cirrhosis: Trial Data Are in but the Jury Is Still Out.
     Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07970.
     PubMed    
     
     
     
117. MUKUND A, Marri UK, Jindal A, Choudhury A, et al
     Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
     Dig Dis Sci. 2023 May 12. doi: 10.1007/s10620-023-07930.
     PubMed     Abstract available
     
     
     
118. SANDHU S, John BV
     Spontaneous Bacterial Peritonitis: The Bug Matters.
     Dig Dis Sci. 2023;68:1667-1669.
     PubMed    
     
     
     
119. FUREY C, Zhou S, Park JH, Foong A, et al
     Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis.
     Dig Dis Sci. 2023;68:2140-2148.
     PubMed     Abstract available
     
     
     April 2023
120. CHOW KW, Ibrahim BM, Yum JJ, Dang A, et al
     Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.
     Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07935.
     PubMed     Abstract available
     
     
     
121. GARG R, Mohammed A, Singh A, Siddiki H, et al
     Mortality Trends, Outcomes, and Predictors of Portal Vein Thrombosis in Acute Pancreatitis Patients: A Propensity-Matched National Study.
     Dig Dis Sci. 2023 Apr 25. doi: 10.1007/s10620-023-07945.
     PubMed     Abstract available
     
     
     
122. WANG CL, Huang CH, Wu VC, Wu CL, et al
     Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C.
     Dig Dis Sci. 2023 Apr 18. doi: 10.1007/s10620-023-07943.
     PubMed     Abstract available
     
     
     
123. PATERNOSTRO R
     Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
     Dig Dis Sci. 2023;68:1089-1090.
     PubMed    
     
     
     
124. UNALP-ARIDA A, Ruhl CE
     Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
     Dig Dis Sci. 2023;68:1237-1252.
     PubMed     Abstract available
     
     
     
125. MAHMUD N, Reddy KR, Taddei TH, Kaplan DE, et al
     Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study.
     Dig Dis Sci. 2023;68:1632-1640.
     PubMed     Abstract available
     
     
     March 2023
126. PROTOPAPAS AA, Savopoulos C, Skoura L, Goulis I, et al
     Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
     Dig Dis Sci. 2023 Mar 24. doi: 10.1007/s10620-023-07858.
     PubMed     Abstract available
     
     
     
127. SMITH HT, de Souza AR, Thompson AH, McLaughlin MM, et al
     Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
     Dig Dis Sci. 2023 Mar 18:1-21. doi: 10.1007/s10620-023-07862.
     PubMed     Abstract available
     
     
     
128. KHALIFA A, Obeid JS, Gregoski MJ, Rockey DC, et al
     Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
     Dig Dis Sci. 2023 Mar 10. doi: 10.1007/s10620-023-07876.
     PubMed     Abstract available
     
     
     
129. CALMET FH, Martin P
     Acid Test: MELD-Lactate Enhances Prediction in Patients with Variceal Hemorrhage.
     Dig Dis Sci. 2023;68:723-724.
     PubMed    
     
     
     
130. SINGAL AG, Parikh ND, Hoshida Y
     Precision HCC Surveillance: It Is All in the Number (Needed).
     Dig Dis Sci. 2023;68:720-722.
     PubMed    
     
     
     
131. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
     Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2023;68:1006-1015.
     PubMed     Abstract available
     
     
     
132. ELHENCE A, Anand A, Biswas S, Vaishnav M, et al
     Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
     Dig Dis Sci. 2023;68:1016-1025.
     PubMed     Abstract available
     
     
     January 2023
133. DAHMUS J, Hummer B, Rivas G, Schmitz K, et al
     Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.
     Dig Dis Sci. 2023 Jan 24. doi: 10.1007/s10620-022-07809.
     PubMed     Abstract available
     
     
     December 2022
134. LI T, Liu J, Zhao J, Bai Y, et al
     Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
     Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07806.
     PubMed     Abstract available
     
     
     
135. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
     Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
     Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
     PubMed     Abstract available
     
     
     
136. TAHATA Y, Sakamori R, Yamada R, Kodama T, et al
     Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.
     Dig Dis Sci. 2022 Dec 16. doi: 10.1007/s10620-022-07629.
     PubMed     Abstract available
     
     
     November 2022
137. CURRAN C, Priest M, Datta S, Forrest EH, et al
     Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
     Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07731.
     PubMed     Abstract available
     
     
     October 2022
138. LIU CH, Jiang W, Wu DB, Zeng QM, et al
     Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
     Dig Dis Sci. 2022 Oct 13. pii: 10.1007/s10620-022-07695.
     PubMed     Abstract available
     
     
     September 2022
139. KHAKOO NS, Sultan S, Reynolds JM, Levy C, et al
     Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07704.
     PubMed     Abstract available
     
     
     June 2022
140. MAYO MJ, Carey E, Smith HT, Mospan AR, et al
     Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
     Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07581.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.